| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
179,711,000 as of 6/30 |
| Market
Cap: |
13.29(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$40.16 - $73.74 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 298 |
| Guru Rank Value : 3.1 |
| Guru Occurances : 4 |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
Company Profile Life Technologies is a life sciences company. Co. provides a range of products and services, including systems, instruments, reagents, software, and custom services. Co.'s portfolio of products includes technologies for capillary electrophoresis-based sequencing, other sequencing systems, polymerase chain reaction, sample preparation, cell culture, ribonucleic acid interference analysis, functional genomics research, proteomics and cell biology applications, as well as clinical diagnostic applications, forensics and animal, food, pharmaceutical and water testing analysis. Co. operates its business under three divisions: Molecular Biology Systems; Cell Systems; and Genetic Systems.
|
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
28,880 |
| Total Buy Value |
$0 |
$0 |
$0 |
$1,213,050 |
| Total People Bought |
0 |
0 |
0 |
5 |
| Total Buy Transactions |
0 |
0 |
0 |
5 |
| Total Shares Sold |
0 |
20,000 |
215,072 |
259,546 |
| Total Sell Value |
$0 |
$1,021,180 |
$10,734,623 |
$12,867,484 |
| Total People Sold |
0 |
1 |
5 |
8 |
| Total Sell Transactions |
0 |
1 |
6 |
14 |
| End Date |
2013-02-21 |
2012-11-20 |
2012-05-22 |
2011-05-23 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
Iyer Balakrishnan S |
Director |
|
2013-04-29 |
4 |
OE |
$73.68 |
$360,148 |
D/D |
4,888 |
8,888 |
|
- |
|
Uprichard David C |
Director |
|
2013-04-26 |
4 |
OE |
$73.74 |
$360,441 |
D/D |
4,888 |
4,940 |
|
- |
|
Levine Arnold J |
Director |
|
2013-04-25 |
4 |
OE |
$73.70 |
$1,432,138 |
D/D |
19,432 |
21,735 |
|
- |
|
Lorimier Bradley G |
Director |
|
2013-04-25 |
4 |
OE |
$73.70 |
$2,355,747 |
D/D |
31,964 |
21,170 |
|
- |
|
Levine Arnold J |
Director |
|
2013-04-24 |
4 |
OE |
$73.70 |
$90,061 |
D/D |
1,222 |
2,303 |
|
- |
|
Andrews Ronald Asbury |
President, Medical Sciences |
|
2013-04-02 |
4 |
D |
$65.75 |
$79,755 |
D/D |
(1,213) |
7,357 |
|
- |
|
Andrews Ronald Asbury |
President, Medical Sciences |
|
2013-04-02 |
4 |
OE |
$65.75 |
$201,655 |
D/D |
3,067 |
8,570 |
|
- |
|
Hoffmeister David F |
Chief Financial Officer |
|
2013-04-02 |
4 |
D |
$65.75 |
$175,421 |
D/D |
(2,668) |
84,804 |
|
- |
|
Hoffmeister David F |
Chief Financial Officer |
|
2013-04-02 |
4 |
OE |
$65.75 |
$336,114 |
D/D |
5,112 |
87,472 |
|
- |
|
Leddy Peter Michael |
SVP, Global Human Resources |
|
2013-04-02 |
4 |
D |
$65.75 |
$105,266 |
D/D |
(1,601) |
40,326 |
|
- |
|
Leddy Peter Michael |
SVP, Global Human Resources |
|
2013-04-02 |
4 |
OE |
$65.75 |
$201,655 |
D/D |
3,067 |
41,927 |
|
- |
|
Lucier Gregory T |
Chief Executive Officer |
|
2013-04-02 |
4 |
D |
$65.75 |
$789,197 |
D/D |
(12,003) |
28,945 |
|
- |
|
Lucier Gregory T |
Chief Executive Officer |
|
2013-04-02 |
4 |
OE |
$65.75 |
$1,512,382 |
D/D |
23,002 |
40,948 |
|
- |
|
Stevenson Mark |
President & COO |
|
2013-04-02 |
4 |
OE |
$65.75 |
$688,994 |
D/D |
10,479 |
102,728 |
|
- |
|
Stevenson Mark |
President & COO |
|
2013-04-02 |
4 |
D |
$65.75 |
$359,521 |
D/D |
(5,468) |
97,260 |
|
- |
|
Richard Kelli |
Chief Accounting Officer |
|
2013-04-02 |
4 |
D |
$65.75 |
$37,938 |
D/D |
(577) |
11,754 |
|
- |
|
Richard Kelli |
Chief Accounting Officer |
|
2013-04-02 |
4 |
OE |
$65.75 |
$100,861 |
D/D |
1,534 |
12,331 |
|
- |
|
Cottingham John A |
Chief Legal Officer |
|
2013-04-02 |
4 |
OE |
$65.75 |
$201,655 |
D/D |
3,067 |
13,492 |
|
- |
|
Cottingham John A |
Chief Legal Officer |
|
2013-04-02 |
4 |
D |
$65.75 |
$105,266 |
D/D |
(1,601) |
11,891 |
|
- |
|
Lucier Gregory T |
Chief Executive Officer |
|
2013-04-01 |
4 |
D |
$64.57 |
$1,264,539 |
D/D |
(19,584) |
17,946 |
|
- |
|
Lucier Gregory T |
Chief Executive Officer |
|
2013-04-01 |
4 |
OE |
$64.57 |
$2,423,312 |
D/D |
37,530 |
37,530 |
|
- |
|
Pescovitz Ora H. |
Director |
|
2013-04-01 |
4 |
A |
$0.00 |
$0 |
D/D |
409 |
5,143 |
|
- |
|
Leddy Peter Michael |
SVP, Global Human Resources |
|
2013-04-01 |
4 |
OE |
$64.57 |
$363,529 |
D/D |
5,630 |
41,798 |
|
- |
|
Leddy Peter Michael |
SVP, Global Human Resources |
|
2013-04-01 |
4 |
D |
$64.57 |
$189,707 |
D/D |
(2,938) |
38,860 |
|
- |
|
Cottingham John A |
Chief Legal Officer |
|
2013-04-01 |
4 |
D |
$64.57 |
$189,707 |
D/D |
(2,938) |
10,425 |
|
- |
|
776 Records found
|
|
Page 1 of 32 |
|
|